非小细胞肺癌表皮生长因子受体酪氨酸激酶抑制剂（英文）[精品文档].pptVIP

* * There was an association between symptom improvement and overall survival in both studies.1,2 References Douillard J-Y et al. Ann Oncol 2002; 13 (Suppl 5): 127, abs 480. Lynch TJ et al. ATS 2003; poster B-111. * I will briefly introduce the design of the study, and Mr Tanaka will present the main efficacy data, including the subset analyses in oriental patients. I will then present the safety data and summarise our presentation. In ISEL, 1692 patients were randomised to Iressa or placebo on a 2:1 basis in 210 centres across 28 countries. While there were no Japanese sites included in thi